HIPEC With Mitomycin C Reduces Locoregional Recurrence in High-Risk Colon Cancer
(MedPage Today) -- Credit: Corrado bellini
Adding hyperthermic intraperitoneal chemotherapy (HIPEC) with mitomycin C to surgery for locally advanced colorectal cancer (CRC) significantly reduced the risk of locoregional recurrence, the randomized...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Colon Cancer | Colorectal Cancer | Gastroenterology